Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia.

Pediatric CBF-AML was a unique setting of prognostic subtypes. Chemotherapy produced good responses. Additional chromosomal abnormalities was the only independent risk factor for OS in pediatric CBF-AML.